ROC curve was implemented to further verify the effect of PTPRH expression and clinicopathological features in predicting 3-year survival, and the AUC values of PTPRH, tumor stage, T, N, and combination of PTPRH and clinicopathological features were 0.616, 0.676, 0.605, 0.645, and 0.707, respectively (Figure 3(b)). Here, PTPRH is linked to neoplasm.